Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Background Cognitive impairment is a common non‐motor symptom in Multiple Sclerosis (MS), negatively affecting autonomy and Quality of Life (QoL). Innovative rehabilitation strategies, such as semi‐immersive virtual reality (VR) and computerized cognitive training (CCT), may offer advantages over traditional cognitive rehabilitation (TCR ...
Maria Grazia Maggio +8 more
wiley +1 more source
A bright future for heritage buildings. How to promote energy efficient retrofitting measures [PDF]
, 2015 Energy System Analysis +2 more
core
Energy Analysis and Heat Integration in the Joint Process of Biomass Fast Pyrolysis and In Line Sorption Enhanced Steam Reforming. [PDF]
Energy FuelsComendador P +5 more
europepmc +1 more source
Cytological-energy analysis of pleural effusions with predominance of neutrophils. [PDF]
Ther Adv Respir Dis, 2020 Matuchova I +7 more
europepmc +1 more source
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Neurochemical levels measured by brain MR spectroscopy (MRS) have been proposed as endpoints for clinical trials in early‐stage spinocerebellar ataxia (SCA) trials. We tested their trial‐readiness by quantifying neurochemicals in three affected brain regions in early‐stage cohorts of SCA2 and SCA3, examining their reproducibility in ...
James M. Joers +19 more
wiley +1 more source
Energy efficient retrofitting in practice. Challenges and opportunities of three heritage buildings in Europe. [PDF]
, 2015 Energy System Analysis +2 more
core
Crystal structure, Hirshfeld surface and inter-molecular inter-action energy analysis of the halogen-bonded 1:1 cocrystal 1-bromo-3,5-di-nitro-benzene-<i>N</i>,<i>N</i>-di-methyl-pyridin-4-amine. [PDF]
Acta Crystallogr E Crystallogr CommunBosch E.
europepmc +1 more source
Digital Cognitive Testing in Mitochondrial Disease: Validity and Challenges for Clinical Trial Use
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Background Primary mitochondrial disease is a group of genetic disorders caused by pathogenic variants in nuclear or mitochondrial DNA, often resulting in progressive neurodegeneration and cognitive decline. Current management is primarily supportive, though recent research offers hope for disease‐modifying treatments in the future.
Oksana Pogoryelova +9 more
wiley +1 more source
Targeting Plasmodium falciparum Schizont Egress Antigen-1 in Infected Red Blood Cells: Docking-Based Fingerprinting, Density Functional Theory, Molecular Dynamics Simulations, and Binding Free Energy Analysis. [PDF]
Pharmaceuticals (Basel)Almasoudi HH, Nahari MH.
europepmc +1 more source
Deep Learning Pose Estimation for Phenotyping of Co‐Occurring Hyperkinetic Movement Disorders
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective To explore whether routine outpatient video combined with deep learning‐based pose estimation and clinically interpretable kinematic features can support multi‐label phenotyping of co‐occurring hyperkinetic movement disorders (HMDs).
Laura Cif +17 more
wiley +1 more source